President Trump’s threat to impose 30% tariffs on the European Union disrupted negotiations. From cars to wine, these are the ...

A plan to acquire and operate what is expected to become the world’s most powerful commercial quantum computer has been ...

Trump’s budget proposal, from May, seeks to slash the Department of Health and Human Services’ budget by $31.3 billion ...

Pfizer and Novo Nordisk have underperformed the market over the past year. Pharmaceutical giants Pfizer (NYSE: PFE) and Novo ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030.

You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by ...

The Danish Meteorological Institute (DMI) has updated its weather warning issued earlier today. According to the latest ...

As the global obesity medication market skyrockets, South Korean pharmaceuticals are rushing to develop national obesity drugs. Currently, the global industry is dominated by GLP-1 (glucagon-like ...

A recent spot check revealed that drugstores in Nairobi, including online pharmacies, are selling more insulin than in ...

Novo Nordisk sees solid Q1 results, major GLP-1 growth potential, and limited downside despite guidance cut and rising risks.

The Novo Nordisk Foundation and the Danish State Loan Fund announced on Thursday that they are investing in the world's most ...

Morgans healthcare and life sciences expert Iain Wilkie fills in for Scott Power this week, covering what the health movers ...